An online training resource for cancer registrars
Official title: SEER*EDUCATE BASE AWARD
Funded at Fred Hutchinson Cancer Center · NIH-11219268 · Data updated 2026-11-12
This study is looking at how an online training program called SEER*Educate helps cancer registrars learn the best ways to collect important cancer data, making sure they have the latest tools and resources to do their job well.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | September 17, 2024 |
| Project end | August 16, 2025 |
| Funding year | 2024 |
| Award (this year) | $441,908 |
| NIH project number | 261201800004I-0-759102400001-1 |
| Project ID | NIH-11219268 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include students and professionals involved in cancer registration and data collection.
✕Less likely to help
Patients who are not involved in cancer registration or do not require cancer data collection services may not receive direct benefits from this research.
What this research studies
SEER*Educate is an innovative online platform designed to train cancer registrars, providing essential resources and coding exercises for effective cancer data collection. With over 3,700 active users annually, including students and professionals from various cancer registries, the program supports educational curricula and mentorships across the country. The training material is continuously updated to reflect the latest data collection needs, ensuring that registrars are well-equipped to handle their responsibilities in cancer surveillance and reporting.
Why it matters
Potential benefit: If successful, this research could enhance the quality and accuracy of cancer data collection, ultimately improving cancer care and outcomes for patients.
How similar studies have gone: Previous initiatives in cancer registrar training have shown success in improving data quality and registry efficiency, indicating that this approach is both effective and necessary.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Schwartz, Stephen — Fred Hutchinson Cancer Center
- Study coordinator: Schwartz, Stephen
Related research
Other NIH-funded projects on the same topics.
-
How brain glia prune neuron fragments in a worm model
Researchers study how brain support cells called glia remove pieces of living neurons in a tiny worm to learn about brain aging and diseases like Alzheimer's.
-
Understanding and Targeting Lineage Plasticity in Prostate Cancer with Genomic-Based Neoadjuvant Therapy
A broad research program at Fred Hutchinson Cancer Center is exploring how aggressive prostate cancers change their cell states in response to therapy and how to block these changes.
-
Personalized cancer drug testing on patient tumor cells
Aiming to test many FDA-approved cancer drugs on a patient’s own tumor cells to identify effective options when standard therapies fail.
-
MOSAAIC: Using health records to track heart disease in Asian American Communities
A big, dedicated effort is testing whether electronic health records can more quickly and accurately track heart and blood vessel problems in Asian American populations.
-
Targeting gut microbes to prevent progression to multiple myeloma
Researchers are testing how specific gut bacteria might trigger immune changes linked to early blood cancer stages and whether targeting these microbes could help prevent progression to multiple myeloma.
-
eDyNAmiC: Understanding extrachromosomal DNA in cancer and how it drives aggressiveness
A cancer research project at Fred Hutchinson Cancer Center is studying abnormal circular DNA pieces (ecDNA) that help cancers grow and resist treatment, with the aim of finding ways to help patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.